Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000666311 | SCV000790582 | likely pathogenic | Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | 2017-03-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000666311 | SCV000814509 | pathogenic | Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | 2023-05-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp313*) in the GALT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GALT are known to be pathogenic (PMID: 22944367). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 551291). This premature translational stop signal has been observed in individual(s) with galactosemia (PMID: 22944367). |
Baylor Genetics | RCV000666311 | SCV004198548 | pathogenic | Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | 2023-04-11 | criteria provided, single submitter | clinical testing |